Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · Real-Time Price · USD

1.720

-0.110 (-6.01%)

At close: Mar 9, 2026, 4:00 PM EDT

1.690

-0.030 (-1.74%)

After-hours: Mar 9, 2026, 7:51 PM EDT

Adial Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-7.98	-13.2	-5.12	-12.73	-19.42	Upgrade
Depreciation & Amortization	0	0	0	0	0.06	Upgrade
Asset Writedown & Restructuring Costs	-	-	-	-	1.55	Upgrade
Loss (Gain) on Equity Investments	0.49	0.55	0.19	-	-	Upgrade
Stock-Based Compensation	0.68	0.8	1.75	3.37	4.24	Upgrade
Other Operating Activities	-0.15	4.54	-1.83	1.94	0.17	Upgrade
Change in Accounts Payable	0.36	0.17	-0.16	0.02	-0.35	Upgrade
Change in Other Net Operating Assets	0.11	0.22	-0.63	-1.19	1.82	Upgrade
Operating Cash Flow	-6.49	-6.92	-6.81	-11.19	-11.95	Upgrade
Capital Expenditures	-	-	-	-	-0.06	Upgrade
Sale of Property, Plant & Equipment	-	-	1.5	-	-	Upgrade
Cash Acquisitions	-	-	-	-	0.03	Upgrade
Other Investing Activities	0.15	-	-	-	-	Upgrade
Investing Cash Flow	0.15	-	1.5	-	-0.03	Upgrade
Issuance of Common Stock	8.47	7.85	0.75	9.13	13.64	Upgrade
Repurchase of Common Stock	-	-	-0	-	-	Upgrade
Other Financing Activities	-	-	3.38	-	-	Upgrade
Financing Cash Flow	8.47	7.85	4.13	9.13	13.64	Upgrade
Net Cash Flow	2.13	0.92	-1.17	-2.06	1.66	Upgrade
Free Cash Flow	-6.49	-6.92	-6.81	-11.19	-12.01	Upgrade
Free Cash Flow Per Share	-9.71	-35.67	-119.45	-279.23	-403.94	Upgrade
Levered Free Cash Flow	-3.77	-3.99	-3.29	-4.67	-5.33	Upgrade
Unlevered Free Cash Flow	-3.77	-3.99	-3.29	-4.67	-5.33	Upgrade
Change in Working Capital	0.47	0.39	-0.79	-1.17	1.46	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.